The purpose of this study is to assess the safety and efficacy of switching to ELAZOP from
prior pharmacotherapy in patients with open-angled glaucoma.
Drug: Elazop (Azarga)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01055366
Ages eligible for Study
18 Years to 80 Years
Genders eligible for Study
Accepts Healthy Volunteers
18 years of age or older.
Clinical diagnosis of ocular hypertension, primary open-angle or pigment dispersion glaucoma in both eyes.
Must be on a stable regimen of Intraocular Pressure (IOP) lowering medication (i.e., either a single therapeutic agent or two separate ocular hypotensive agents) for at least one month prior to the Screening Visit.
Must have IOP considered to be safe (in the opinion of the investigator), in both eyes, in such a way that should assure clinical stability of vision and the optic nerve throughout the study period.
Must be willing to discontinue the use of all other ocular hypotensive medications prior to receiving the study medication for the entire course of the study.
Other protocol-defined inclusion criteria may apply.
Known medical history of allergy, hypersensitivity, or poor tolerance to any component of the preparations to be used in the study that is deemed clinically significant in the opinion of the Principal Investigator.
Intraocular conventional surgery or laser surgery in either eye less than three months prior to the Screening visit.
History of ocular herpes simplex.
Pregnant or lactating.
Participation in any other investigational study within 30 days of Screening visit.
Other protocol-defined exclusion criteria may apply.
All locations for NCT01055366
Korea, Republic of (10)
Seoul National University Bundang Hospital
Sungnam, Gyounggi, Korea, Republic of, 463-707
Youngnam Univ. Hospital
Daegu, Korea, Republic of, 705-707
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Yonsei University Severance Hospital
Seoul, Korea, Republic of, 120-752
Samsung Medical Center
Seoul, Korea, Republic of, 135-710
Yonsei University Kangnam Severance Hospital
Seoul, Korea, Republic of, 135-720
Seoul St. Mary's Hospital, The Catholic University of Korea
Seoul, Korea, Republic of, 137-040
Asan Medical Center
Seoul, Korea, Republic of, 138-706
Kim's Eye Hospital
Seoul, Korea, Republic of, 150-034
St. Mary's Hospital, The Catholic University of Korea
Seoul, Korea, Republic of, 150-703
View full eligibility
Tris trial is registered with FDA with number: NCT01055366. The sponsor of the trial is Alcon Research and it is looking for 96 volunteers for the current phase.
Official trial title:
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.